Navigation Links
SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award
Date:4/30/2009

AMSTERDAM, April 30 /PRNewswire/ -- SynCo Bio Partners B.V. (Amsterdam, The Netherlands), the cGMP manufacturer of clinical and commercial biopharmaceuticals, has won the Vaccine Industry Excellence (ViE) award for Best Contract Manufacturing Organization (CMO) 2009. This award was presented to SynCo at the Washington World Vaccine Congress on the 22nd of April and is a recognition of the excellent work by SynCo's scientists and manufacturing staff on behalf of its clients over the last 9 years.

SynCo was nominated by a panel of judges from the industry and selected over 5 other finalists in the Best CMO category, according to a wide range of criteria including:

    - The range of services provided in niche and core therapeutic
      areas
    - Methods of performance improvement or introduction of new
      services
    - Attention to and quality of relationships with clients
    - Reaching of milestones and final / ongoing outcomes
    - Building and maintaining existing and long term partnerships

Pierre Warffemius, CEO, said 'this award endorses SynCo's aim to be the long term strategic choice of biotechnology companies for the development of production processes and the GMP manufacture of protein, live-microbial, polysaccharide and monoclonal antibody-based biopharmaceuticals."

Issued on behalf of SynCo Bio Partners by De Facto Communications For more information, contact:

About SynCo Bio Partners B.V.

SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with in-depth clinical and commercial production experience with mammalian and microbial systems. This experience has been acquired by developing new production processes for a number of international clients and producing a wide variety of different vaccines, live bacterial products and recombinant proteins in our state-of-the-art, GMP-licensed facilities since inception in 2000.

Focused solely on biopharmaceuticals, SynCo Bio Partners acts as a strategic, long-term partner delivering your product on time and to the highest quality standards. All our staff are committed to exceeding customer expectations and believe that taking a truly collaborative approach to manufacturing is the key to a successful outcome.

http://www.syncobiopartners.com


'/>"/>
SOURCE SynCo Bio Partners B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SynCo Bio Partners Completes Manufacture and Release of ActoGeniX Lead Product for Phase II Clinical Trials
2. Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities
3. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
4. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
5. DecisionQ Partners With Thomas Jefferson University to Reveal Insights for Cancer Therapy
6. E&K Scientific Announces Partnership with Sciformatix
7. PRA International Presents Key Budgeting Strategies at 18th Annual CRO Partnerships Conference
8. Isis and Partners Present New Research at the American Association for Cancer Research 2009 Annual Meeting
9. Brazils top automakers to distribute 2 million copies of the Ethanol Handbook in partnership with the Brazilian Sugarcane Industry Association
10. Childrens Memorial Research Center, Chicago Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
11. ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... NY (PRWEB) , ... January 20, 2017 , ... Nipro ... a Joint Venture (JV) under which Nipro will receive exclusive marketing and sales rights ... to establish best practices for hemodialysis patients in Japan, the new Nipro - Transonic ...
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... Kan. , Jan. 20, 2017 Aratana ... therapeutics company focused on the licensing, development and commercialization ... Animal Pharm,s Best Company in North ... granted the award based on the FDA ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) ...
(Date:1/20/2017)... ... 2017 , ... The two newest companies to join the University City Science ... out from The Wistar Institute, and Sanguis, launched by a trio of students from ... , Vironika is developing a treatment for a chronic viral infection and its associated ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... --  IdentyTechSolutions America LLC , a leading provider ... a cutting-edge manufacturer of software and hardware security ... integrated solutions that comprise IDT biometric readers and ... IdentyTech,s customers with combined physical identification and anti-tailgating ... theft. "We are proud to use ...
(Date:12/16/2016)... , Dec. 16, 2016 The global wearable medical device ... billion by 2021 from USD 5.31 billion in 2016, at a ... ... driven by technological advancements in medical devices, launch of a growing ... for wireless connectivity among healthcare providers, and increasing focus on physical ...
Breaking Biology News(10 mins):